Pharmacology and Toxicology
Showing page 17 of 22 pages of list content
-
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
This article's authors -
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
This article's authors -
Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike – ACE2 Protein-Protein Interaction – A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19
This article's authors -
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug
This article's authors -
Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders
This article's authors -
A phenomics approach forin vitroantiviral drug discovery
This article's authors -
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
This article's authors -
Development of a highly sensitive bioanalytical assay for the quantification of favipiravir
This article's authors -
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
This article's authors -
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs
This article's authors